Introduction
Bloody tears is an uncommon clinical occurrence that is usually associated with trauma or lesions of the cornea, conjunctiva, lacrimal gland or sac, and systemic diseases. [1] [2] [3] [4] We report a case of a 24-year-old male who presented with bloody tears following an attack of erythema multiforme-like drug eruption.
Case report
A 24-year-old man was referred from the dermatology clinic with a diagnosis of erythema multiforme-like drug eruption that developed after receiving cefazolin sodium 1000 mg intravenously for an upper respiratory tract infection. The patient had no family history of any ocular or systemic disease. He developed severe chronic conjunctivitis in his left eye, which resulted in minor symblephara and dry eye after 10 months. The dry eye was controlled with hourly administration of preservative-free artificial tears and punctual plug insertion.
One year later, the patient developed recurrent bloody tears in his left eye and several hematomas in the left periorbital region ( Figure 1A ). During one of the attacks, he had hemorrhage from the left external auditory meatus and epistaxis on several occasions ( Figure 1B ). Complete ophthalmologic examination was within normal limits, except for severe dry eye and symblephara on the left side. The right side also had mild dry eye manifestations. Best corrected visual acuity was 20/20 bilaterally. 
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Complete blood cell count and coagulation tests, including prothrombin time, partial thromboplastin time, bleeding time, and international normalized ratio were all within normal limits. He was widely investigated for rheumatologic disorders, collagen tissue diseases, and vasculitic conditions. Advanced investigations, including anti-Jo-1, anti-RNP, anti-Scl-70, anti-Sm, anti-SS-A, anti-SS-B, antinuclear antibodies, perinuclear antineutrophil cytoplasmic antibodies, PR3, anticardiolipin, IgM, and IgG were within normal limits. Psychiatric examination was normal. Ear, nose, and throat examination performed during attacks of epistaxis revealed blood in the inferior meatus, but the exact location of the hemorrhage could not be located. Imaging, including computerized tomography and magnetic resonance imaging of the cranium and orbital regions, in addition to transcanalicular endoscopic evaluation of the lacrimal drainage system, revealed no pathology. The lacrimal sac and surrounding tissues were explored and multiple biopsies were obtained from the lacrimal sac, ethmoidal mucosa, and angular vein. Nonspecific chronic inflammatory cells were detected in the soft tissues, and angular vein biopsy was normal. Immunohistochemical studies were not contributory. A left carotid and ophthalmic artery angiography was performed in order to evaluate the vascular structure in vivo. Angiography showed small vascular dilatations, and an increase in vascular permeability at the medial canthal and inferior palpebral regions (Figure 2 ).
Vitamin C 1000 mg daily for one month was prescribed. The patient continued to have unilateral bloody tears intermittently, but the episodes became less frequent and then stopped after three years.
Discussion
Bloody tearing is a rare clinical phenomenon that may be caused by a wide range of pathologies. The association of this entity with conjunctival lesions, including vascular tumors and malformations, 1 chronic actinomyces canaliculitisrelated punctal pyogenic granuloma, 3 and hereditary hemorrhagic telangiectasis, 2 have been reported in isolated cases. Tumors of the lacrimal apparatus have also been known to cause bloody tears. 4 Other reported causes include corneal vascular lesions, 2 vicarious ocular menstruation, 5 severe epistaxis with regurgitation through the lacrimal passages, 6 and orbital varix. 7 Self-inflicted wounds of the conjunctiva causing bloody tears have been reported. 8 In addition, cases of idiopathic bloody tearing which classically resolve without treatment are known to exist. 9 In this case, we could not identify any local cause or a systemic condition to explain the finding. The only positive finding resulting from the extensive investigation was the presence of chronic perivascular inflammatory infiltrates in the soft tissues around the lacrimal drainage apparatus, and dilatation and extravasation in the terminal branches of the external carotid ophthalmic artery system. Even though the patient had a diagnosis of erythema multiforme-like drug eruption from dermatologic evaluation, the ophthalmologic appearance was more consistent with erythema multiforme or Stevens-Johnson syndrome. We speculate that although erythema multiforme is a pathology of small dermal vessels, larger blood vessels are known to show vasculitis and perivasculitis. 10 Episodic conjunctival inflammation after Stevens-Johnson syndrome was described by Foster et al. They reported that ultrastructural and immunopathologic characteristics of the conjunctiva in these patients were totally different from those without recurrent conjunctivitis, suggesting an immunologically-mediated active inflammation resulting in vasculitis or perivasculitis. 10 In this case, it is conceivable that bloody tearing may have been a result of increased vascular permeability in the peripalpebral area and the medial canthal region due to disturbed vascular hemodynamics.
It is assumed that spontaneous generation of superoxide is increased in patients with vasculitic diseases. Free oxygen radicals have also been shown in vitro to be important in the pathogenesis of vasculitis and can be reduced with administration of antioxidants like vitamin C, increasing the body's ability to prevent free radical-mediated oxidative damage and improving endothelial dysfunction. 12 Administration of vitamin C 1000 mg daily to promote vascular stabilization might have had a role in controlling the symptoms. On the other hand, the possibility that the decrease in frequency of attacks might represent the natural course of the disease cannot be ruled out.
In conclusion, we suggest that the bleeding might have resulted from increased vascular permeability following the inflammatory process, and it responded well to high dose vitamin C as an antioxidant. To the best of our knowledge, this is the first report relating increased vascular permeability to the etiology of recurrent bloody tears.
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